Global On-body Injectors Market Report, History and Forecast 2018-2029

Global On-body Injectors Market Report, History and Forecast 2018-2029

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global On-body Injectors market was valued at US$ 143.67 million in 2022 and will reach US$ 358.98 million by the end of 2029, growing at a CAGR of 15.00% during 2023-2029.

North American market for On-body Injectors was valued at $ 75.86 million in 2022 and will reach $ 188.15 million by 2029, at a CAGR of 14.46% during the forecast period of 2023 through 2029.

Asia-Pacific market for On-body Injectors was valued at $ 13.97 million in 2022 and will reach $ 38.19 million by 2029, at a CAGR of 17.00% during the forecast period of 2023 through 2029.

Europe market for On-body Injectors was valued at $ 49.61 million in 2022 and will reach $ 122.49 million by 2029, at a CAGR of 15.31% during the forecast period of 2023 through 2029.

Report Scope

This report aims to provide a comprehensive presentation of the global market for On-body Injectors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding On-body Injectors.

The On-body Injectors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global On-body Injectors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global On-body Injectors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

Market Segmentation

This report covers the On-body Injectors segments by manufacturers, by Type, by Application, by region and country, and provides market size (value, volume and average price) and CAGR for the history and forecast period (2018-2022, 2023-2029), considering 2022 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.

By Company

West Pharmaceutical Services

Insulet

Gerresheimer

United Therapeutics

CC Bio

BD

Ypsomed

Enable Injections

Nemera

Stevanato Group

Sonceboz

Lohmann Therapie-Systeme

Elcam Drug Delivery Devices (E3D)

Segment by Type

Electronic Injectors

Mechanical Injectors

Segment by Application

Immuno-oncology

Cardiovascular Diseases

Neurological Diseases

Others

By Region

North America

United States

Canada

Asia-Pacific

China

Japan

South Korea

China Taiwan

India

Southeast Asia

Europe

Germany

France

U.K.

Italy

Switzerland

Latin America, Middle East and Africa

Brazil

Israel

Turkey

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East and Africa, Middle East & Africa.

Chapter Two: Detailed analysis of On-body Injectors manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter Three: Sales, revenue of On-body Injectors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East and Africa, Middle East & Africa.

Chapter Five, Six, Seven and Eight: North America, Europe, Asia Pacific, Latin America, Middle East and Africa, sales and revenue by country.

Chapter Nine: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter Ten: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter Eleven: Analysis of sales channel, distributors and customers.

Chapter Twelve: Research Findings and Conclusion.